Want to track SPRY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ars Pharmaceuticals Inc (SPRY) Statistics
Valuation metrics
Market Cap 969.2M
Enterprise value 1.04B
Trailing P/E (ttm) -4.9
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) 9.79
Price/Book (mrq) 15.81
Enterprise Value/Revenue 10.53
Enterprise Value/EBITDA -5.42
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.32M
Average volume (90 days) 1.74M
Price summary
52-Week low 6.66
52-Week high 18.9
Beta -
50-Day moving average 8.29
200-Day moving average 9.33
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2%
Operating margin -2.04%
Operational effectiveness
Return on assets -0.69%
Return on equity -1.54%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.99
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.02
Total debt (mrq) -
Total Debt/Equity (mrq) 1.58
Current ratio (mrq) 4.94%
Book value per share (mrq) 0.62
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
